SB1752 adds a new criminal offense in Arizona law targeting mescaline when it is harvested, processed, or made available for commercial use or research. The bill defines “commercial use” broadly to include transactions or uses intended for financial gain, profit, or business-related purposes, and it defines “research” to include medical and pharmaceutical investigation, study, and experimentation. A person who knowingly violates the new section would be guilty of a class 4 felony.
The bill also creates a religious-use defense. In a prosecution under the new section, it is a defense if the mescaline is being used or intended for use as part of the bona fide practice of a religious belief, as an integral part of a religious exercise, and in a manner not dangerous to public health, safety, or morals. The bill references the existing statutory definition of mescaline in Arizona’s drug laws and amends Title 13, chapter 34 by adding section 13-3402.01.
Impact
SB1752 would expand Arizona’s controlled-substance enforcement framework by specifically criminalizing the commercial or research-related handling of mescaline, even beyond ordinary possession or sale language. It would create a new class 4 felony offense under Title 13 for knowingly harvesting, processing, or making mescaline available for those purposes, while preserving a narrow religious-use defense. The bill would affect individuals, businesses, and researchers involved with mescaline, including those pursuing medical or pharmaceutical applications, and would likely increase legal risk for any commercial activity involving the substance.
Sentiment
The available voting history suggests generally favorable sentiment toward the bill in the Senate, with the Senate Health and Human Services Committee reporting it out 7-0 and the Senate Third Reading passing 21-7. The Rules Committee action is listed as PFC, indicating procedural movement rather than substantive opposition. Overall, the bill appears to have had meaningful support, though the final floor vote shows some dissent.
Contention
The main point of contention appears to be the bill’s broad restriction on mescaline for “commercial use or research,” which could be seen as reaching medical, pharmaceutical, or other research activities that are not traditionally associated with trafficking. Supporters likely view the measure as a drug-control and public-safety bill, while opponents may be concerned that it could chill legitimate research or business activity involving mescaline. The religious-use defense may also be a point of discussion, as it creates an exception but only under specific conditions tied to bona fide religious practice and public safety.
Controlled substances: penalties; conduct associated with qualified psychoactive substances; exempt from criminal penalties in certain circumstances. Amends secs. 7401, 7403 & 7404 of 1978 PA 368 (MCL 333.7401 et seq.).